We are live on
!
Find out more
CG
Carlyle Group Portfolio holdings
AUM
$10.6B
1-Year Est. Return
11.25%
This Fund
S&P 500
This Quarter
Est. Return
-19.9%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$5.8B
AUM Growth
-$2.56B
(-31%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuidelOrtho
QDEL
|
+$1.27B |
| 2 |
EM
Smart Share Global Ltd
EM
|
+$6.01M |
| 3 |
AIU
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
|
+$484K |
| 4 |
SEACOR Marine Holdings
SMHI
|
+$385K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$2.2B |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 51.28% |
| 2 | Technology | 23.89% |
| 3 | Healthcare | 22.72% |
| 4 | Consumer Staples | 1.89% |
| 5 | Industrials | 0.12% |
Similar funds
SGA
PF
BMSSC
EAM
WAM
HTC
CA
OIA
Carlyle Group's Q2 2022 Portfolio in Review
As of Q2 2022, Carlyle Group held 10 positions worth $5.8B, down 31% from $8.36B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Carlyle Group withdrew a net $952M in Q2 2022, closing 1 position and reducing 1 holding. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $2.2B position sold in full.
By sector, the portfolio is most concentrated in Materials at 51% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Carlyle Group opened a new position in QuidelOrtho worth $1.21B.
- Carlyle Group's largest Q2 2022 buy was QuidelOrtho: 12,460,183 shares worth $1.21B.
- Carlyle Group added most to SEACOR Marine Holdings in Q2 2022, an estimated $385K increase.
- Carlyle Group's biggest Q2 2022 reduction was ZoomInfo Technologies, cutting an estimated $25.3M.
- Carlyle Group fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $2.2B.
- Carlyle Group's ten largest holdings make up 100% of its $5.8B portfolio in Q2 2022.
- Carlyle Group opened 3 new positions and closed 1 in Q2 2022.
- Carlyle Group's portfolio value fell 31% quarter-over-quarter to $5.8B.
Based on Carlyle Group's 13F filing for Q2 2022, filed 12 Aug 2022.